Medical Journalism in the War on Alzheimer’s
They say that truth is the first casualty of war. So how is the truth doing in news coverage of medical research on dementia now that we have finally declared War on Alzheimer’s? The question is...
View ArticleHistory and the Will to Power in the Alzheimer’s Field
It is a strange time to be a historian interested in Alzheimer’s disease. On the one hand, since the putative one hundredth anniversary of Alzheimer’s disease, which was confusingly celebrated in both...
View ArticleWill Failure of Plaque Clearing Drugs Bring Change in the AD Field?
With the news that Pfizer and Johnson & Johnson are scrapping further study of the drug bapineuzumab (bapi) after its second failure in a major clinical trial, and expectations no better for...
View ArticleScrutinizing Alzheimer’s Science
A couple of weeks back, I wrote a post that offered some constructive criticism to Allen Power. As I said then, I have great respect for Power as a leader in the efforts to change the culture of...
View ArticleThe New Yorker on Dementia: Crisis in Scientific Research and Progress in...
The peer-reviewed article may be the coin of the realm in academic science, but the high profile magazine article is the bellwether of popular attitudes toward health, medicine and disease. Thus it’s...
View ArticleSkewering the Emerging “Brain Fitness” Industry
Perhaps I should look into joining The New Yorker as a staff writer now that major articles on dementia seem to have become a regular feature of the magazine. In this week’s issue, humorist Patricia...
View ArticleClimate Change, Alzheimer’s Disease and the Conundrum of Scientific Authority.
There is perhaps no greater source of authority in modern society than science. As a result, scientific claims are nearly ubiquitous, and often controversial. How do we decide when to trust and when...
View Article
More Pages to Explore .....